Morgan Stanley downgraded Santander Mexico BSMX from Overweight to Equal-weight and lowered the price target from $18.00 to $16.00.
Morgan Stanley noted, "4Q12 results raise questions about BSMX's recurring earnings in 2013-14. Net income was M$3,310 million (M$0.49/share and US$0.19/ADR), 25% below our estimate of M$4,416 million, and 20% below consensus of M$4,153 million. Even excluding non-recurring items, earnings run-rate is significantly below the pre-IPO level. Most notably, higher credit costs will likely continue in 2013-14, pressuring the bottom-line. We are lowering our 2013-14e EPS by 18-19%. We see ROAE at 18-19%, below management guidance of ~20%."
Santander Mexico closed at $15.18 on Tuesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in